ARTICLE | Company News
NovImmune, Roche deal
August 2, 2010 7:00 AM UTC
NovImmune granted Roche's Genentech Inc. unit exclusive rights to a preclinical anti-IL-17 human mAb, with access to backup antibodies. NovImmune will receive an upfront payment and is eligible for m...